Palliative Care

Also known as: Palliative treatment

DrugDrug NameDrug Description
DB06800MethylnaltrexoneMethylnaltrexone is a pheriphally-acting μ-opioid antagonists that acts on the gastrointestinal tract to decrease opioid-induced constipation without producing analgesic effects or withdrawal symptoms. It is also a weak CYP2D6 inhibitor. FDA approved in 2008.
DrugDrug NamePhaseStatusCount
DB06515Resiniferatoxin1 / 2Recruiting1
DB09061Cannabidiol2Completed1
DB00470Dronabinol2Completed1
DB01221Ketamine2Recruiting1
DB00281Lidocaine2Completed1
DB08896Regorafenib2Terminated1
DB12335Tanezumab2Completed1
DB09085Tetracaine2Completed1
DB00171ATP3Completed1
DB09061Cannabidiol3Completed1
DB00470Dronabinol3Completed1
DB00813Fentanyl3Withdrawn1
DB00215CitalopramNot AvailableCompleted1
DB11089DocusateNot AvailableCompleted1
DB00422MethylphenidateNot AvailableCompleted1
DB11365SennosidesNot AvailableCompleted1